JSPR

JASPER THERAPEUTICS INC

JSPR·471871202·US·Common Stock·Healthcare - Biotechnology-Activist

JSPR (JASPER THERAPEUTICS INC) is held by 28 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($493,421), Carlyle Group Inc. ($448,866), MILLENNIUM MANAGEMENT LLC ($204,999). Net institutional sentiment: Bearish.

28
Holders
(2 Elite)
$1.7M
Total Value
23% (30)
Consensus
7 buying - 23 selling
13F: Insider & Congress: Updated regularly
JSPR

Smart Money Verdict

View all
Loading verdict
Held by 28 funds
2 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Sep 24, 2025 · Activists Aug 17, 2026 · Congress none

ActivistVIVelan Capital Investment Management LP9.9%Aug 17, 2026
ActivistVMVelan Capital Master Fund LP8.9%Jul 20, 2026
ActivistMIMillennium Management LLC1.7%Jul 10, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
1.2M(-0.1%)$493,4210.0%-46.02%
0
Unchanged
1.1M$448,8660.0%-96.18%
0
Decreased
486,933(-69.9%)$204,9990.0%-64.91%
0
Decreased
263,808(-17.0%)$111,0860.0%-93.32%
0
Increased
237,900(+34.0%)$100,1560.0%-64.53%
28
Decreased
169,627(-29.9%)$71,4130.0%-96.01%
0
Unchanged
149,943$63,1260.0%-46.02%
0
Increased
101,743(+375.1%)$42,8340.0%+8.92%
22
Decreased
58,759(-27.6%)$24,7370.0%-82.91%
0
Increased
51,185(+184.0%)$21,5490.0%-20.49%
30
Increased
45,850(+12.2%)$19,2980.0%-72.66%
14
Unchanged
44,699$18,8180.0%-96.34%
0
Increased
41,882(+21.1%)$17,6320.0%-95.78%
15
New
33,722$14,1970.0%+70.55%
27
Decreased
33,406(-15.3%)$14,0640.0%-46.02%
0
Decreased
28,591(-2.3%)$12,0360.0%-46.02%
0
Increased
19,930(+2152.0%)$8,3910.0%+41.56%
18
Decreased
14,192(-95.2%)$5,9750.0%-95.90%
0
Decreased
13,538(-73.7%)$5,6990.0%-70.53%
0
Decreased
12,989(-50.3%)$5,4680.0%-54.59%
0

Showing 1-20 of 38

1 / 2
JSPRJSPRJASPER THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used